bims-resufa Biomed News
on Respiratory supercomplex factors
Issue of 2025–10–05
two papers selected by
Gavin McStay, Liverpool John Moores University



  1. Plant Physiol. 2025 Sep 30. pii: kiaf471. [Epub ahead of print]
      Transcripts in plant mitochondria and chloroplasts undergo editing prior to translation, with approximately 500 specific sites edited in mitochondria and about 30 in plastids of the model plant Arabidopsis (Arabidopsis thaliana). Although the full role of this mechanism is not yet understood, it is presumed to compensate for unfavorable mutations accumulated over evolutionary periods. It is also conceivable that RNA editing serves a regulatory function, as proteins can be translated from partially unedited transcripts. In this study, we characterize proteins derived from such mitochondrial transcripts. To enrich these proteins, we use an Arabidopsis multiple organellar RNA editing factor 3 (MORF3) mutant, which exhibits reduced RNA editing at numerous specific sites. Despite developmental delays, the mutant plants remain fertile. Physiological and biochemical analyses reveal that complex I of the respiratory chain is particularly affected in the mutants. Consistent with these findings, a shotgun proteomic analysis identified proteins originating from partially unedited NADH dehydrogenase subunit 2 (nad2) and nad7 transcripts. Complexome profiling revealed that these proteins integrate into the holo-complex and, to a lesser extent, into the supercomplex formed by complex I and dimeric complex III. Concurrently, known assembly intermediates of complex I are enriched in the mutant. We demonstrate that the disruption of complex I assembly is caused by the absence of editing at specific sites in transcripts encoding the subunits Nad3 and Nad4L. Our results provide deep insights into the molecular consequences of perturbations within the respiratory complex I.
    Keywords:   Arabidopsis thaliana ; MORF3; Multiple Organellar RNA Editing Factor 3; RNA editing; complex I; complexome profiling; plant mitochondria; protein complex assembly; respiratory chain
    DOI:  https://doi.org/10.1093/plphys/kiaf471
  2. Proc Natl Acad Sci U S A. 2025 Oct 07. 122(40): e2506761122
      MEPAN (Mitochondrial Enoyl CoA Reductase Protein-Associated Neurodegeneration) is an early-onset movement disorder characterized by ataxia, dysarthria, and optic atrophy. Here, we report the creation of a mouse model of MEPAN with patient-similar compound heterozygous mutations in the Mecr gene. The MEPAN mouse recapitulates the major hallmarks of MEPAN, including a movement disorder, optic neuropathy, defects in protein lipoylation, and reduced mitochondrial oxidative phosphorylation in the brain. MECR catalyzes the last step in mitochondrial fatty acid synthesis (mtFASII), and the mechanism by which loss of mtFASII leads to neurological disease is unknown. LC-MS/MS-based proteomic analysis of Mecr mutant cerebella identified loss of subunits of complex I of oxidative phosphorylation (OXPHOS) and subunits of the iron-sulfur cluster assembly (ISC) complex. Native gels revealed altered OXPHOS complex and supercomplex formation and changes in binding of the acyl carrier protein (ACP) to mitochondrial complexes. These results demonstrate that MECR plays a key role in the acylation of ACP which is necessary for ACP-LYRM-mediated supercomplex modulation and ISC biogenesis and suggest unique pathways for therapeutics.
    Keywords:  genetics; iron; mitochondrial disease; mitochondrial fatty acid synthesis; mouse model
    DOI:  https://doi.org/10.1073/pnas.2506761122